Harley H A, Mason R, Phillips P J
Med J Aust. 1983 Jul 9;2(1):41-2. doi: 10.5694/j.1326-5377.1983.tb142088.x.
A case of profound hypocalcaemia which occurred in a patient with osteoblastic metastatic carcinoma of the prostate after treatment with oestrogens is reported. Although there may have been other contributory factors, it was felt that the administration of oestrogens was the most important causative element. Treatment with high doses of oestrogens in patients with osteoblastic metastatic carcinoma of the prostate should be accompanied by frequent measurements of plasma calcium levels.
报告了一例前列腺成骨性转移性癌患者在接受雌激素治疗后发生严重低钙血症的病例。尽管可能存在其他促成因素，但认为雌激素的使用是最重要的致病因素。对于前列腺成骨性转移性癌患者，使用高剂量雌激素治疗时应频繁测量血浆钙水平。
